Clinical Trials Directory

Trials / Completed

CompletedNCT03292562

A Comparison of Methods of Discontinuing Nasal CPAP in Premature Infants <30 Weeks Gestation

A Comparison of Methods of Discontinuing Nasal CPAP in Premature Infants <30 Weeks Gestation - a Feasibility Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
66 (actual)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if among infants \<30 weeks gestational age on nasal continuous positive airway pressure (NCPAP), whether discontinuing CPAP after gradual reduction in continuous positive airway pressure (CPAP) pressure leads to successful weaning off CPAP when compared to discontinuing CPAP without weaning pressure.

Conditions

Interventions

TypeNameDescription
DEVICEDiscontinue NCPAP after weaning pressuresAfter randomization, CPAP pressure will be weaned by 1 every 24hours as long as the subjects continue to meet stability criteria after each wean, until CPAP of 4. If after decrease in CPAP pressure, the subject meets CPAP failure criteria pressure will be increased back to the previous level and after stabilization for 24 hours weaning process will be started again. Once the subject meets stability criteria on CPAP of 4, NCPAP will be stopped and subject will be placed on nasal cannula (NC) according to unit guidelines (max 1 Liter flow, 30% FiO2).
DEVICEDiscontinue NCPAP without weaning pressuresAfter randomization, once the subject meets stability criteria, NCPAP will be stopped and subject will be placed on nasal cannula (NC) according to unit guidelines (max 1 Liter flow, 30% FiO2).

Timeline

Start date
2017-09-19
Primary completion
2019-03-01
Completion
2019-03-31
First posted
2017-09-25
Last updated
2020-03-17
Results posted
2020-03-17

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03292562. Inclusion in this directory is not an endorsement.